Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
China De Xiao Quan Care Group Co., Ltd (CDXQ)
New York City, NY, US
China De Xiao Quan Care Group Co., Ltd presently conducts no significant business operations. Its past activities, however, centered on the development and commercialization of technologies for the medical cannabis market. The entity was formerly known as Nhale, Inc. Established in 2012, the company maintains its base in New York, New York.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | 0.00% | 0.00% | +66.67% | +150.00% | +400.00% | +400.00% | -94.12% | -98.08% | -92.54% | -99.90% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Shell Companies: +20.6%—
-
EPS growth Shell Companies: -12.3%+116.9% ★ Q2'23: +182.6% (vs Q2'22)
-
FCF margin FCF growth · Shell Companies: +8.7%—
-
EBIT margin Shell Companies: +0.0%—
-
ROIC Shell Companies: +0.0%— Q2'23: -530.7% (vs Q2'22)
-
Share dilution Shell Companies: -10.2%+1,666.7% Q2'23: +1,666.7% (vs Q2'22)
-
Debt / EBITDA Net debt/EBITDA · Shell Companies: 0.00×— Q2'23: 0.05× (vs Q2'22)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chunsheng Qin | President, Chief Executive Officer, Secretary, Treasurer & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CDXQ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
